Foodborne botulism
diseaseOn this page
Also known as intoxication botulism
Summary
Foodborne botulism (MONDO:0016453) is a disease. A subtype of botulism — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
At a glance
- Prevalence: Unknown (Worldwide) [Orphanet-validated]
- Phenotypes (HPO): 19
Clinical features
Epidemiology
Prevalence records
3 prevalence record(s), Orphanet:
| Type | Class | Value | Geography | Validation |
|---|---|---|---|---|
| Annual incidence | 1-9 / 1 000 000 | 0.1 | Europe | Validated |
| Annual incidence | <1 / 1 000 000 | 0.01 | United States | Validated |
| Annual incidence | 1-9 / 1 000 000 | 0.18 | Romania | Validated |
Signs & symptoms
Clinical features (HPO)
19 HPO clinical features (Orphanet curated; top 19 by frequency):
| HPO ID | Term | Frequency |
|---|---|---|
| HP:0000217 | Xerostomia | Very frequent (80-99%) |
| HP:0000508 | Ptosis | Very frequent (80-99%) |
| HP:0000651 | Diplopia | Very frequent (80-99%) |
| HP:0001260 | Dysarthria | Very frequent (80-99%) |
| HP:0001324 | Muscle weakness | Very frequent (80-99%) |
| HP:0002014 | Diarrhea | Very frequent (80-99%) |
| HP:0002015 | Dysphagia | Very frequent (80-99%) |
| HP:0002019 | Constipation | Very frequent (80-99%) |
| HP:0002027 | Abdominal pain | Very frequent (80-99%) |
| HP:0003470 | Paralysis | Very frequent (80-99%) |
| HP:0006597 | Diaphragmatic paralysis | Very frequent (80-99%) |
| HP:0006824 | Cranial nerve paralysis | Very frequent (80-99%) |
| HP:0011499 | Mydriasis | Very frequent (80-99%) |
| HP:0100021 | Cerebral palsy | Very frequent (80-99%) |
| HP:0000016 | Urinary retention | Frequent (30-79%) |
| HP:0002017 | Nausea and vomiting | Frequent (30-79%) |
| HP:0002747 | Respiratory insufficiency due to muscle weakness | Frequent (30-79%) |
| HP:0011675 | Arrhythmia | Frequent (30-79%) |
| HP:0006543 | Cardiorespiratory arrest | Occasional (5-29%) |
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | foodborne botulism |
| Mondo ID | MONDO:0016453 |
| Orphanet | 228371 |
| DOID | DOID:0050352 |
| ICD-11 | 2033726602 |
| NCIT | C128341 |
| SNOMED CT | 398523009 |
| UMLS | C1739094 |
| MedGen | 320728 |
| GARD | 0020591 |
| Is cancer (heuristic) | no |
Also known as: intoxication botulism
Disease family
This is a subtype of botulism. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.
Classification path: disease › human disease › disease by etiologic mechanism › disease of primarily extrinsic mechanism › infectious disease › bacterial infectious disease › primary bacterial infectious disease › botulism › foodborne botulism
Related subtypes (3): toxin-mediated infectious botulism, inhalational botulism, iatrogenic botulism
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 0.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.